A dose escalation, randomized, placebo-controlled study designed to investigate the safety, feasibility and initial efficacy of local injections of plasminogen formulation for the treatment of chronic tympanic membrane perforation.

Trial Profile

A dose escalation, randomized, placebo-controlled study designed to investigate the safety, feasibility and initial efficacy of local injections of plasminogen formulation for the treatment of chronic tympanic membrane perforation.

Planning
Phase of Trial: Phase I

Latest Information Update: 06 Nov 2017

At a glance

  • Drugs Plasminogen (Primary)
  • Indications Wounds
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 06 Nov 2017 New trial record
    • 01 Nov 2017 According to a ProMetic Life Sciences media release, company has received clearance from the Swedish Medical Products Agency to initiate plasminogen clinical trial in chronic tympanic membrane perforation.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top